Asset
INDIPLON
Neurocrine Biosciences Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00525941 | phase3 | withdrawn | 2007-09-01 | 2008-01-01 | Neurocrine Biosciences | An Exploratory Study of NBI-34060 Capsules and Next Day Functioning |
FDA applications (0)
This company has no applications containing this asset.